Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NowPatient vs QuickMD

NowPatient
Graded #222

Higher grade

vs+0.5999999999999943
QuickMD
Graded #237

Lower grade

The verdict

NowPatient takes it — 65.5/100 to 64.9/100, but only just.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda. QuickMD is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQuickMD +10
35
45
Dose & formulationNowPatient +17
93
76
Clinical oversightEven
86
86
Labs & monitoringNowPatient +2
54
52
FulfillmentQuickMD +1
70
71
Contract termsQuickMD +6
55
61
NowPatient · left barQuickMD · right bar

The numbers

MetricNowPatientQuickMD
WeighScore65.5/10064.9/100
GradeCC
Scorecard rank#222#237
Semaglutide$1,349/mo (brand Wegovy)$279/mo (compounded)
Tirzepatide$1,069/mo (brand Mounjaro, promotional rate)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
NowPatient

Graded #222 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)
QuickMD

Graded #237 · C

Strengths

  • Compounded semaglutide around $279/mo plus brand-name GLP-1 options
  • Same-day, 365-day-a-year online visits
  • Large established platform with over 1 million completed visits
  • Transparent cash-pay pricing with reimbursement summaries
  • Can prescribe Wegovy, Zepbound, Ozempic, Mounjaro, Rybelsus

Where it loses points

  • Does not accept insurance
  • Available in 45+ states, not all 50
  • Medication cost varies by pharmacy, not fully bundled
  • No named board-certified physicians listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard